Jecure Therapeutics
Biotechnology - San Diego, California, United States of America
Jecure Therapeutics Employees
Jecure Therapeutics Details
Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure's academic founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician-scientist in hepatology. With operations in the biotech hub of San Diego, California, Jecure combines emerging NASH biology from Dr. Feldstein's lab with an elite discovery team of veteran pharma/biotech scientists. Jecure's lead program has identified small molecule inhibitors of a novel target and pro-inflammatory driver of NASH. Jecure is backed by top-tier life science investor Versant Ventures.
Jecure Therapeutics Technologies
Domain Name Services
Cloudflare DNS
CMS
WordPress.org
Tag Management
Google Tag Manager
Hosting
CloudFlare Hosting
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework